Inclusion Criteria:
Participants must meet all of the following criteria for inclusion in the study:
- Age ≥18 years old.
- Histologic confirmation of non-muscle invasive bladder cancer of the transitional cell carcinoma high-grade subtype (mixed histology tumors allowed if transitional cell histology is predominant histology).
- Ineligible to participate in a clinical trial using rMBCG or geographically unable to access a rMBCG clinical trial site.
- Voluntary written informed consent and agreement to comply with all protocol specified procedures and follow-up evaluations.
Exclusion Criteria:
Participants with any of the following criteria are excluded from participation in the study:
- Other illness or condition, including laboratory abnormalities, which in the opinion of the Investigator would exclude the participant from participating in this study. This includes, but is not limited to, serious medical conditions or psychiatric illness likely to interfere with participation in the study.